SEC 13F Intelligence

AGILE THERAPEUTICS INC

CUSIP 00847L100

Agile Therapeutics Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 35.6K shares worth $99,054 as of Q1 2024.

Institutional Holders
1
Q1 2024
Reported Value
$99,054
Ticker
unmapped
private placement or foreign
Quarters Tracked
16

Ownership Trend

Institutional holders
Q4 ’18: 16Q4 ’18Q1 ’19: 19Q2 ’19: 18Q2 ’19Q3 ’19: 27Q4 ’19: 39Q4 ’19Q1 ’20: 51Q2 ’20: 64Q2 ’20Q3 ’20: 61Q4 ’20: 64Q4 ’20Q1 ’21: 58Q2 ’21: 54Q2 ’21Q3 ’21: 38Q4 ’21: 36Q4 ’21Q1 ’22: 27Q4 ’23: 1Q4 ’23Q1 ’24: 1filingsflow.com
Total reported value
Q4 ’18: $2MQ4 ’18Q1 ’19: $10MQ2 ’19: $10MQ2 ’19Q3 ’19: $10MQ4 ’19: $29MQ4 ’19Q1 ’20: $21MQ2 ’20: $31MQ2 ’20Q3 ’20: $35MQ4 ’20: $35MQ4 ’20Q1 ’21: $21MQ2 ’21: $56MQ2 ’21Q3 ’21: $8MQ4 ’21: $5MQ4 ’21Q1 ’22: $3MQ4 ’23: $20Q4 ’23Q1 ’24: $99,054filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
MetLife Investment Management, LLC$19.6B AUM0.00%$99,05435.6KQ1 2024
Cornerstone Planning Group LLC$749M AUM0.00%$2010Q4 2023OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.